Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes

Abstract Background Given the scarcity of effective therapeutic targets, metastatic triple negative breast cancer (mTNBC) has shorter survival times compared to other advanced breast cancer subtypes. Although chemo-immunotherapy with immune checkpoint inhibitors (ICIs) in PD-L1+ mTNBC has shown prom...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Avia D. Wilkerson, Ivan Juric, Salendra Singh, Patricia A. Rayman, Paul G. Pavicic, Jennifer Powers, Prerana Bangalore Parthasarathy, Zahraa Al-Hilli, Jennifer S. Ko, Timothy Chan, Tyler Alban, Alberto J. Montero, C. Marcela Diaz-Montero
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Nature Portfolio 2025-05-01
श्रृंखला:	Communications Medicine
ऑनलाइन पहुंच:	https://doi.org/10.1038/s43856-025-00860-4
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!